Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections

Immunology Letters

Volumn 51, Issue 1-2, 1996, Pages 95-99

  Fenyö, Eva Maria ^a   Putkonen, Per ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Broadly cross neutralizing activity in serum; HIV 1; HIV 1 transmission; HIV 2; Pathogenesis; SIV neutralization

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; MONKEY; NONHUMAN; PRIORITY JOURNAL; SERUM; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 0030175971     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-2478(96)02561-8     Document Type: Conference Paper

References (31)

1. [1] Sawyer, L.S.W., Wrin, M.T., Crawford-Miksza, L., Potts, B., Wu, Y., Weber, P.A., Alfonso, R.D. and Hanson, C.V. (1994) Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68, 1342-1349.
2. [2] Wrin, T., Loh, T.P., Charron Vennari, J., Schuitemaker, H. and Nunberg, J.H. (1995) Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69, 39-48.
3. [3] Murphey-Corb, M., Martin, L.N., Davison-Fairburn, B., Montelaro, R.C., Allison, A.C. and Eppstein, D.A. (1989) A formalin inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
4. [4] Sutjipto, S., Pedersen, N.C., Miller, C.J., Gardner, M.B., Hanson, C.V., Gettie, A., Jennings, M., Higgins, J. and Marx, P.A. (1990) Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J. Virol. 64, 2290-2297.
5. [5] Carlson, J.R., McGraw, T.P., Keddie, E., Yee, J.L., Rosenthal, A., Langtois, A.J., Dickover, R., Donovan, R., Luciw, P.A., Jennings, M.B. and Gardner, M.B. (1990) Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 6, 1239-1246.
6. [6] Daniel, M.D., Mazzara, G.P., Simon, M.A., Sehgal, P.K., Kodama, T., Panicali, D.L. and Desrosiers, R.C. (1994) High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res. Hum. Retrovir. 10, 839-851.
7. sm infection by passive immunization in cynomolgus monkeys. Nature 352, 434-436.
8. [8] Lewis, M.G., Elkins, W.R., McCutchan, F.E., Benveniste, R.E., Lai, C.Y., Montefiori, D.C., Burke, D.S., Eddy, G.A. and Shafferman, A. (1993) Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine 11, 1347-1355.
9. [9] Shafferman, A., Lewis, M.G., McCutchan, E.F., Benveniste, R.E., Jahrling, P.B., Burke, D.S. and Eddy, G.A. (1993) Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. Vaccine 11, 848-852.
10. [10] Clements, J.E., Montelaro, R.C., Zink, M.C., Amedee, Martin A., Miller, S., Trichel, A.M., Jagerski, B., Hauer, D., Martin, L.N., Bohm, R.P. and Murphey-Corb, M. (1995) Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69, 2737-2744.
11. mac251. AIDS Res. Hum. Retrovir. 10, 189-194.
12. [12] Gardner, M., Rosenthal, A., Jennings, M., Yee, J.A., Antipa, L. and MacKenzie, M. (1994) Passive immunization of macaques against SIV infection. J. Med. Primatol. 23, 164-174.
13. sm). J. AIDS 2, 359-365.
14. [14] Putkonen, P., Böttiger, D., Warstedt, K., Thorstensson, R., Albert, J. and Biberfeld, G. (1989) Experimental infection of cynomolgus monkeys (Macaco fascicularis) with HIV-2. J. AIDS 2, 366-367.
15. sm isolates in experimentally infected cynomolgus monkeys correlate to prognosis. Virology 197, 609-615.
16. SBL6669 in nonpathogenic infection of macaques. Virology 200, 583-589.
17. [17] Scarlatti, G., Lombardi, V., Plebani, A., Principi, N., Vegni, C., Ferraris, G., Bucceri, A., Fenyö, E.M., Wigzell, H., Rossi, P. and Albert, J. (1991) Polymerase chain reaction, virus isolation and antigen assay in HIV-1 antibody positive mothers and their children. AIDS 5, 1173-1178.
18. [18] Fiore, J.R., Björndal, Å., Aperia-Peipke, K., Di Stefano, M., Angarano, G., Pastore, G., Gaines, H., Fenyö, E.M. and Albert, J. (1994) The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204, 297-303.
19. [19] Scarlatti, G., Leitner, T., Halapi, E., Wahlberg, J., Marchisio, P., Clerici-Schoeller, M.A., Wigzell, H., Fenyö, E.M., Albert, J., Uhlén, M. and Rossi, P. (1993) Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. USA 90, 1721-1725.
20. [20] Scarlatti, G., Hodara, V., Rossi, P., Muggiasca, L., Bucceri, A., Albert, J. and Fenyö, E.M. (1993) Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 197, 624-629.
21. [21] Sundqvist, V.A., Albert, J., Ohlsson, E., Hinkula, J., Fenyö, E.M. and Wahren, B. (1989) Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29, 170-175.
22. [22] Thorstensson, R., Walther, L., Putkonen, P., Albert, J. and Biberfeld, G. (1991) A capture enzyme immunoassay for detection of HIV-2/SIV antigen. J. AIDS 4, 374-379.
23. [23] Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nyström, G. and Fenyö, E.M. (1990) Rapid development of isolate-specific neutralizing antibodies after primary HIV-I infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4, 107-112.
24. [24] von Gegerfelt, A., Albert, J. Morfeldt-Månson, L., Broliden, K. and Fenyö, E.M. (1991) Isolate-specific neutralizing antibodies in patients with progressive HIV-1 related disease. Virology 185, 162-168.
25. [25] Albert, J., Björling, E., von Gegerfelt, A., Scarlatti, G., Zhang, Y.-J. and Fenyö. E.M. (1993) Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays. AIDS Res. Hum. Retrovir. 9, 501-504.
26. [26] Scarlatti, G., Albert, J., Rossi, P., Hodara, V., Biraghi, P., Muggiasca, L. and Fenyö, E.M. (1993) Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168, 207-210.
27. [27] Björling, E., Scarlatti, G., von Gegerfelt, A., Albert, J., Biberfeld, G., Chiodi, F., Norrby, E. and Fenyö, E.M. (1993) Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193, 529-530.
28. [28] Fenyö, E.M., Fiore, J.R., Scarlatti, G. and Albert, J. (1995) Viral markers of HIV-1 transmission. Biotech. 94: Biotechnology against AIDS 36, 127-134.
29. [29] WHO Network for HIV Isolation and Characterization (1994) HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retrovir. 10, 1327-1344.
30. [30] Pau, C.P., Kai, M., Hollomon-Candal, D.L., Luo, C.C., Kalish, M.L., Schochetman, G., Byers, B., George, J.R. and the WHO Network for HIV Isolation and Characterization (1994) Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. AIDS Res. Hum. Retrovir. 10, 1369-1378.
31. [31] Cheingsong-Popov, R., Lister, S., Callow, D., Kalebu, P., Beddows, S., Weber, J. and the WHO Network for HIV Isolation and Characterization (1994) Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. AIDS Res. Hum. Retrovir. 10, 1379-1386.